Brief: Daré Bioscience Announces Publication Of Phase 1/2 Pharmacokinetic, Safety And Pharmacodynamic Data For Dare-VVA1 - A Potential New Hormone-Free Treatment For Vulvovaginal Atrophy - In Climacteric, The Journal Of The International Menopause Society

Dare Bioscience

09/06/2023 13:02

June 9 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES PUBLICATION OF PHASE 1/2
PHARMACOKINETIC, SAFETY AND PHARMACODYNAMIC DATA FOR DARE-VVA1 -
A POTENTIAL NEW HORMONE-FREE TREATMENT FOR VULVOVAGINAL ATROPHY
- IN CLIMACTERIC, THE JOURNAL OF THE INTERNATIONAL MENOPAUSE
SOCIETY
    * DARE BIOSCIENCE INC - DATA FROM STUDY DEMONSTRATED SAFETY
AND
TOLERABILITY OF INVESTIGATIONAL PRODUCT DARE-VVA1

Source text for Eikon:  ID:nGNX2R8CLw 
Further company coverage:  DARE.O 

 ((reuters.briefs@thomsonreuters.com;))